GESTION BOUTIQUE IV/JPB GLOBAL ALLOCATION · 23 posiciones
| 5,69 % |
Exelixis Inc US30161Q1040 | 5,54 % |
ARGENX SE US04016X1019 | 5,24 % |
Mesoblast Ltd US5907171046 | 3,51 % |
Oncotherapy Science JP3202150003 | 3,50 % |
Mirati Therapeutics US60468T1051 | 3,38 % |
Guardant Health Inc US40131M1099 | 3,30 % |
Teladoc Health Inc. US87918A1051 | 3,15 % |
Pluristem Therapeuti US72940R3003 | 3,15 % |
CRISPR Therapeutics CH0334081137 | 2,90 % |
Ginko Bioworks Holdi US37611X1000 | 2,48 % |
Abcellera Biologics CA00288U1066 | 2,35 % |
908 Devices Inc US65443P1021 | 2,34 % |
Illumina Inc US4523271090 | 2,22 % |
Corbus Pharmaceutica US21833P1030 | 1,93 % |
Vascular Biogenics L IL0011327454 | 1,91 % |
G1 Therapeutics Inc US3621LQ1099 | 1,60 % |
Co-Diagnostics Inc US1897631057 | 1,52 % |
Biolase Inc US0909112072 | 1,21 % |
ETF Direxion Daily F US25490K3234 | 0,64 % |